These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

867 related items for PubMed ID: 30070323

  • 1. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
    Cai Y, Dong ZY, Wang JY.
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
    [Abstract] [Full Text] [Related]

  • 2. Effect of lncRNA-BLACAT1 on drug resistance of non-small cell lung cancer cells in DDP chemotherapy by regulating cyclin D1 expression.
    Ju ZS, Sun B, Bao D, Zhang XF.
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9465-9472. PubMed ID: 33015788
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ, Wu YP, Wang D, Zhou ZH, Xue SB, Zhang DY, Wei YG, Liu W.
    Med Sci Monit; 2019 Oct 29; 25():8095-8104. PubMed ID: 31659146
    [Abstract] [Full Text] [Related]

  • 4. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB, Wang SX.
    Eur Rev Med Pharmacol Sci; 2019 Feb 29; 23(3):1093-1101. PubMed ID: 30779077
    [Abstract] [Full Text] [Related]

  • 5. Downregulated long non-coding RNA TRPM2-AS inhibits cisplatin resistance of non-small cell lung cancer cells via activation of p53- p66shc pathway.
    Ma LY, Xie XW, Ma L, Pang JL, Xiong XM, Zheng HD, Shen XL, Wen ZG, Wang HY.
    Eur Rev Med Pharmacol Sci; 2017 Jun 29; 21(11):2626-2634. PubMed ID: 28678322
    [Abstract] [Full Text] [Related]

  • 6. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
    Liu B, Pan CF, Ma T, Wang J, Yao GL, Wei K, Chen YJ.
    Mol Med Rep; 2017 Oct 29; 16(4):4107-4112. PubMed ID: 29067469
    [Abstract] [Full Text] [Related]

  • 7. Reelin Promotes Cisplatin Resistance by Induction of Epithelial-Mesenchymal Transition via p38/GSK3β/Snail Signaling in Non-Small Cell Lung Cancer.
    Li JM, Yang F, Li J, Yuan WQ, Wang H, Luo YQ.
    Med Sci Monit; 2020 Aug 07; 26():e925298. PubMed ID: 32764530
    [Abstract] [Full Text] [Related]

  • 8. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
    Yu DJ, Li YH, Zhong M.
    Eur Rev Med Pharmacol Sci; 2019 Jun 07; 23(11):4800-4806. PubMed ID: 31210311
    [Abstract] [Full Text] [Related]

  • 9. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3.
    Qi MM, Ge F, Chen XJ, Tang C, Ma J.
    Eur Rev Med Pharmacol Sci; 2019 Jun 07; 23(12):5242-5250. PubMed ID: 31298375
    [Abstract] [Full Text] [Related]

  • 10. SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway.
    Chen K, Abuduwufuer A, Zhang H, Luo L, Suotesiyali M, Zou Y.
    Eur Rev Med Pharmacol Sci; 2019 Aug 07; 23(16):6935-6943. PubMed ID: 31486493
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH, Luo N, Zhong MZ, Xiao ZQ, Wang JX, Yao XY, Peng Y, Cao J.
    Tumour Biol; 2016 Feb 07; 37(2):2387-94. PubMed ID: 26376998
    [Abstract] [Full Text] [Related]

  • 12. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R, Zhang FH, Shen N.
    Biomed Pharmacother; 2017 Nov 07; 95():331-338. PubMed ID: 28858731
    [Abstract] [Full Text] [Related]

  • 13. Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis.
    Fu J, Cai H, Wu Y, Fang S, Wang D.
    Gene; 2020 Sep 10; 755():144886. PubMed ID: 32534055
    [Abstract] [Full Text] [Related]

  • 14. LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway.
    Xu L, Xu Y, Yang M, Li J, Xu F, Chen BL.
    BMC Pulm Med; 2020 Oct 15; 20(1):266. PubMed ID: 33059643
    [Abstract] [Full Text] [Related]

  • 15. mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9.
    Liu B, Wang R, Liu H.
    Biomed Res Int; 2021 Oct 15; 2021():6622342. PubMed ID: 34055989
    [Abstract] [Full Text] [Related]

  • 16. LncRNA SH3PXD2A-AS1 facilitates cisplatin resistance in non-small cell lung cancer by regulating FOXM1 succinylation.
    Chen Y, Wu S, Han Y, Shi H, Yuan J, Cui W.
    BMC Cancer; 2024 Jul 17; 24(1):848. PubMed ID: 39020302
    [Abstract] [Full Text] [Related]

  • 17. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H, Pu J, Zhou XL, Ning YY, Bai C.
    Tumour Biol; 2017 May 17; 39(5):1010428317697568. PubMed ID: 28459375
    [Abstract] [Full Text] [Related]

  • 18. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
    Feng N, Guo Z, Wu X, Tian Y, Li Y, Geng Y, Yu Y.
    Respir Res; 2021 Sep 18; 22(1):248. PubMed ID: 34537072
    [Abstract] [Full Text] [Related]

  • 19. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P, Cao L, Zheng M, Yao Y, Wang W, Chen X.
    Exp Mol Pathol; 2021 Jun 18; 120():104633. PubMed ID: 33753110
    [Abstract] [Full Text] [Related]

  • 20. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.
    Wang L, Shang X, Feng Q.
    Cancer Biol Ther; 2019 Jun 18; 20(3):261-271. PubMed ID: 30481109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.